Tirzepatide
Anti-diabetic and weight loss medication
Tirzepatide ▸ Facts ▸ Comments ▸ News ▸ Videos
Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. In the United States, it is sold under the brand name Mounjaro for diabetes treatment and Zepbound for weight loss and treatment of obstructive sleep apnea.
| 0 shares | ShareTweetSavePostSend |
You Might Like
Cost of weight-loss drug Mounjaro to be discounted in UK pharmacies when price hike comes into force, Sky News learnsThe cost of Mounjaro, one of Britain's biggest-selling weight loss drugs, will be heavily discounted across UK pharmacies when the official list price soars next week, Sky News has learned.Sky News - Published | |
Maker of popular weight loss drug pauses shipments to UK The manufacturer of the popular weight loss drug Mounjaro has paused shipments to the UK ahead of an upcoming price hike.Sky News - Published | |
Serena Williams Reveals She's Taking Weight Loss Drug ZepboundSerena Williams just revealed she's taking a popular weight loss drug, Zepbound, a GLP-1 medication, admitting she first tried to do it naturally ... but nothing worked! The tennis legend opened up to..TMZ.com - Published | |
Mounjaro manufacturer to hike UK price of weight loss drug by up to 170% The UK cost of weight loss drug Mounjaro will increase by up to 170%, its US manufacturer has said, as the White House pushes for a price hike abroad so costs can be cut for Americans.Sky News - Published | |
Ozempic to Mounjaro - what are the injections and what were they designed to do? Drugs designed to treat diabetes and repurposed as miracle diet aids have taken over TikTok - and Hollywood.Sky News - Published | |
Blockbuster weight loss drug Mounjaro launched, prices starts at Rs 3500 per vialPharma giant Eli Lilly has launched Mounjaro, a popular weight-loss drug, in India. Priced at Rs 3,500 for 2.5 mg and Rs 4,375 for 5 mg, Mounjaro is available by prescription and aims to address..IndiaTimes - Published | |
Weight loss drug gets US nod to treat sleep apnea; India launch likely next yearThe US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending approvals...IndiaTimes - Published |
